Editorial: the diminishing returns of normalisation of the oesophageal mucosa-Authors' reply.

Mastracci, L; Fiocca, R; Engstrom, C; Attwood, S; Ell, C; Galmiche, J P; Hatlebakk, J G; Långström, G; Eklund, S; Lind, T; Lundell, L

Mastracci, L; Fiocca, R; Engstrom, C; Attwood, S; Ell, C; Galmiche, J P; Hatlebakk, J G; Långström, G; Eklund, S; Lind, T; Lundell, L.

Afiliação

Mastracci L; Department of Surgical and Diagnostic Sciences (DISC), Pathology Unit, University of Genova and IRCCS S. Martino/IST University Hospital, Genova, Italy.
Fiocca R; Department of Surgical and Diagnostic Sciences (DISC), Pathology Unit, University of Genova and IRCCS S. Martino/IST University Hospital, Genova, Italy.
Engstrom C; Sahlgrenska universitetssjukhuset, Goteborg, Sweden.
Attwood S; Northumbria Healthcare, North Shields, UK.
Ell C; Sana Klinikum Offenbach, Frankfurt, Germany.
Galmiche JP; Institut des maladies de l'appareil digestif, CHU Hotel-Dieu, Nantes, France.
Hatlebakk JG; Haukeland Universitetssjukehus, Bergen, Norway.
Långström G; R&D, AstraZeneca, Mölndal, Sweden.
Eklund S; Clinical Study Management, AstraZeneca R&D, Mölndal, Sweden.
Lind T; Formerly of AstraZeneca, Gothenburg, Mölndal, Sweden.
Lundell L; Department of Surgery, Gastroenterology, Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.

Aliment Pharmacol Ther ; 46(1): 73-74, 2017 07.

Article em En | MEDLINE | ID: mdl-28589583

Assuntos

Esofagite Eosinofílica; Mucosa Esofágica; Humanos; Inibidores da Bomba de Prótons

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esofagite Eosinofílica / Mucosa Esofágica Limite: Humans Idioma: En Revista: Aliment Pharmacol Ther Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google